Follicle-stimulating hormone or human menopausal gonadotropin for ovarian stimulation in in vitro fertilization cycles: a meta-analysis. (Q52081845)

21 April 2018

meta-analysis

0 references

title

Follicle-stimulating hormone or human menopausal gonadotropin for ovarian stimulation in in vitro fertilization cycles: a meta-analysis. (English)

1 reference

21 April 2018

1 reference

Agrawal R

1

1 reference

21 April 2018

Holmes J

series ordinal

2

1 reference

21 April 2018

Jacobs HS

series ordinal

3

1 reference

21 April 2018

language of work or name

English

0 references

publication date

1 February 2000

1 reference

21 April 2018

published in

Fertility and Sterility

1 reference

21 April 2018

volume

73

1 reference

21 April 2018

issue

2

1 reference

21 April 2018

page(s)

338-343

1 reference

21 April 2018

Follicular development and early luteal function of conception and non-conceptional cycles after human in-vitro fertilization: endocrine correlates

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900519-1

Influence of serum luteinising hormone concentrations on ovulation, conception, and early pregnancy loss in polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900519-1

Hypersecretion of luteinising hormone, infertility, and miscarriage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900519-1

Reevaluation of the roles of luteinizing hormone and follicle-stimulating hormone in the ovulatory process

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900519-1

A randomized comparative study of purified follicle stimulating hormone and human menopausal gonadotropin after pituitary desensitization with Buserelin for superovulation and in vitro fertilization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900519-1

Ovarian stimulation for in vitro fertilization and embryo transfer, human menopausal gonadotropin versus pure human follicle stimulating hormone: a randomized prospective study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900519-1

Follicle stimulating hormone alone supports follicle growth and oocyte development in gonadotrophin-releasing hormone antagonist-treated monkeys.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900519-1

The effect of human menopausal gonadotrophin and highly purified, urine-derived follicle stimulating hormone on the outcome of in-vitro fertilization in down-regulated normogonadotrophic women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900519-1

Developmental potential of embryos produced by in-vitro fertilization from gonadotrophin-releasing hormone antagonist-treated macaques stimulated with recombinant human follicle stimulating hormone alone or in combination with luteinizing hormone.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900519-1

The role of luteinizing hormone in folliculogenesis and ovulation induction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900519-1

Follicle-stimulating hormone versus human menopausal gonadotropin for in vitro fertilization: results of a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900519-1

Ovulation induction with human menopausal gonadotropin compared to human urinary follicle-stimulating hormone results in a significant shift in follicular fluid androgen levels without discernible differences in granulosa-luteal cell function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900519-1

Comparison of urinary human follicle-stimulating hormone and human menopausal gonadotropins for ovarian stimulation in an in vitro fertilization program

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900519-1

Randomized controlled trial of follicle stimulating hormone versus human menopausal gonadotrophin in in-vitro fertilization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900519-1

Comparison of efficacy of high-dose pure follicle-stimulating hormone versus human menopausal gonadotropins for in vitro fertilization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900519-1

A randomized, assessor-blind, group-comparative efficacy study to compare the effects of Normegon and Metrodin in infertile female patients undergoing in-vitro fertilization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900519-1

Nuclear maturity and oocyte morphology after stimulation with highly purified follicle stimulating hormone compared to human menopausal gonadotrophin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900519-1

Different follicle stimulating hormone/luteinizing hormone ratios for ovarian stimulation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900519-1

Pure and highly purified follicle-stimulating hormone alone or in combination with human menopausal gonadotrophin for ovarian stimulation after pituitary suppression in in-vitro fertilization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900519-1

Purified urinary follicle stimulating hormone induces different hormone profiles compared with menotrophins, dependent upon the route of administration and endogenous luteinizing hormone activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900519-1

Controlled ovarian stimulation using highly purified FSH results in a lower serum oestradiol profile in the follicular phase as compared with HMG.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900519-1

A randomized comparative study of highly purified follicle stimulating hormone and human menopausal gonadotrophin for ovarian hyperstimulation in an oocyte donation programme.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900519-1

The role of luteinizing hormone in human follicular maturation and function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900519-1

Stimulation of ovarian follicular maturation with pure follicle-stimulating hormone in women with gonadotropin deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900519-1

Implications of using follicle-stimulating hormone preparations depleted of luteinizing hormone to achieve follicular growth in in vitro fertilization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900519-1

Effects of profound suppression of luteinizing hormone during ovarian stimulation on follicular activity, oocyte and embryo function in cycles stimulated with purified follicle stimulating hormone.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900519-1

Immunocytochemical localization of estradiol and progesterone receptors in the monkey ovary throughout the menstrual cycle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900519-1

Effect of profound suppression of luteinizing hormone during treatment with gonadotrophin-releasing hormone analogue and purified follicle stimulating hormone upon development of cryopreserved embryos

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900519-1

The long protocol of administration of gonadotropin-releasing hormone agonist is superior to the short protocol for ovarian stimulation for in vitro fertilization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900519-1

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0015-0282(99)00519-1

1 reference

21 April 2018

PubMed ID

10685540

1 reference

21 April 2018